Ocuvex Therapeutics, Inc.
PrivateLast Round
M&A
Aug 19, 2024
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ocuvex Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in New Hyde Park, New York. Its latest recorded funding round was a Seed round in August 2022.
Ocuvex Therapeutics, Inc. is a biopharmaceutical company that focuses on the development and commercialization of ophthalmic therapeutic candidates for the treatment of glaucoma and other ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ocuvex Therapeutics, Inc. Comparables
Compare Ocuvex Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ONL Therapeutics | 81% | |
| Qlaris Bio | 81% | |
| Galimedix Therapeutics | 80% |
For institutional investors. Book with your work email.
Ocuvex Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 19, 2024 | ||||
| Seed | Aug 3, 2022 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 101% MoM, reaching 2.8K.
- Jul 25, 2026
Monthly visitors grew 108% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Ocuvex Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ocuvex Therapeutics, Inc.'s valuation, stock price, and market status.
Is Ocuvex Therapeutics, Inc. a public or private company?
Ocuvex Therapeutics, Inc. is a private company.
What is the current stock price of Ocuvex Therapeutics, Inc.?
Ocuvex Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Ocuvex Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ocuvex Therapeutics, Inc. worth (valuation)?
Valuation information for Ocuvex Therapeutics, Inc. is not publicly available.
Can I buy Ocuvex Therapeutics, Inc. stock?
Ocuvex Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ocuvex Therapeutics, Inc.'s last funding round?
Ocuvex Therapeutics, Inc.'s most recent funding round was M&A on August 19, 2024.
Who are the main investors in Ocuvex Therapeutics, Inc.?
Investor information for Ocuvex Therapeutics, Inc. is not publicly disclosed.
Will Ocuvex Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Ocuvex Therapeutics, Inc..
How can I track Ocuvex Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Ocuvex Therapeutics, Inc.'s shares on secondary markets.